Overview

Plasmapheresis Market is estimated to value over USD 2.2 billion by 2027 end with a CAGR of over 8% during the forecast period 2020 to 2027.

Increased incidences of autoimmune diseases, growing insistence for plasma source from biopharma companies, improving healthcare infrastructure and awareness programs in both developed and developing nations, favourable scenario for reimbursements on plasmapheresis processes and other technological advancements are some of the key driving factors responsible for the plasmapheresis market growth.
Plasmapheresis or plasma exchange is a process that involves the separation and removal of plasma from the blood for eliminating an element of a disease present in the plasma. The RBCs, platelets and WBCs are returned to the patient with an additional fluid recommended by the physician. The process of plasmapheresis removes over 15 percent of plasma from the total blood volume of a patient therefore no additional plasma is required to be removed. Plasmapheresis generally involves plasma collection for manufacturing products like albumin, IVIG, factor concentrates and laboratory reagents and for transfusion. Furthermore, the increased incidences of autoimmune disorders have exponentially increased the demand for this procedure across the world.
Autoimmune diseases like celiac diseases, type 1 diabetes, rheumatoid arthritis, lupus and temporal arteritis have increased the plasmapheresis market demand. As per the report published by the CDC, over 9% of the total population of the United States suffer from diabetes and over 30 million people are diagnosed with diabetes across the world. Healthcare companies are consistently improving in the development of plasmapheresis instruments like apheresis machines to provide enhancements in these instruments to conduct this process across the world. Owing to these factors the market is predicted to proliferate during the forecasted timeframe. Moreover, the plasma is required to treat different diseases like anaemia, blood loss, stomach disease, cancer which has surged the insistence for blood donations. Such factors have significantly contributed to the growth of the market.

Plasmapheresis Market

Market Segmentation:

By Product Type
•   Disposables
•   Instruments
By Indication
•   Neurological Disorders
•   Renal Disorders
•   Autoimmune Disorders
•   Metabolic Disorders
•   Hematological Disorders
By Technology
•   Membrane Filtration
•   Centrifugation
By Application
•   Therapeutic Plasmapheresis
•   Source Plasma Collection
By End User
•   Hospitals and Clinics
•   Biopharmaceutical Industry
•   Others
By Region
•   North America
•   Europe
•   Asia-Pacific
•   Latin America
•   Middle East and Africa

The market is fragmented into product type, indication, technology, application, end user and region. The indications segment is classified into renal disorders, neurological disorders, metabolic disorders, haematological disorders and autoimmune disorders. The autoimmune disorders is predicted to hold the largest plasmapheresis market share owing to the rise in the number of patients diagnosed with type 1 diabetes with unhealthy dietary choices. The applications the market is fragmented into source plasma collection and therapeutic plasmapheresis. The source plasma collection is anticipated to experience a substantial growth during the forecasted timeframe. The end user segment is categorised into hospitals and specialty clinics, biopharmaceutical industry and others like blood banks, therapeutic plasma collection centre and blood collection centres.

Regional Analysis:

The North America region is expected to dominate the market owing to improvements in the healthcare infrastructure, rising number of patients with autoimmune and neurological disorders, increased disposable income and rising adoption of plasmapheresis for treating diseases like Wegener’s Granulomatosis, thrombocytopenic purpura, etc.

Competitive Landscape:

Some of the prominent market players associated are Asahi Kasei Corporation, Grifols S.A., Octapharma AG, Kedrion Biopharma (KED Plasma), B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Haemonetics Corporation, Terumo Corporation.

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the global plasmapheresis market by indication, by product type, by technology, by application, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com